Annual Gross Margin
92.70%
+0.91%+0.99%
December 31, 2023
Summary
- As of February 23, 2025, ITCI annual gross profit margin is 92.70%, with the most recent change of +0.91% (+0.99%) on December 31, 2023.
- During the last 3 years, ITCI annual gross margin has risen by +1.11% (+1.21%).
- ITCI annual gross margin is now at all-time high.
Performance
ITCI Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Margin
91.26%
-1.70%-1.83%
September 30, 2024
Summary
- As of February 23, 2025, ITCI quarterly gross profit margin is 91.26%, with the most recent change of -1.70% (-1.83%) on September 30, 2024.
- Over the past year, ITCI quarterly gross margin has stayed the same.
- ITCI quarterly gross margin is now -2.40% below its all-time high of 93.50%, reached on June 30, 2023.
Performance
ITCI Quarterly Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Margin Formula
Gross Margin = Gross Profit
Revenue ✕ 100%
Revenue ✕ 100%
ITCI Gross Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.0% | 0.0% |
| 3 y3 years | +1.2% | 0.0% |
| 5 y5 years | - | 0.0% |
ITCI Gross Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2.8% | -2.4% | +1.3% |
| 5 y | 5-year | at high | +2.8% | -2.4% | +2.2% |
| alltime | all time | at high | +2.8% | -2.4% | +2.2% |
Intra-Cellular Therapies Gross Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 91.26%(-1.8%) |
| Jun 2024 | - | 92.96%(-0.2%) |
| Mar 2024 | - | 93.17%(+1.4%) |
| Dec 2023 | 92.70%(+1.0%) | 91.86%(-0.9%) |
| Sep 2023 | - | 92.74%(-0.8%) |
| Jun 2023 | - | 93.50%(+0.7%) |
| Mar 2023 | - | 92.87%(+0.7%) |
| Dec 2022 | 91.79% | 92.24%(+0.4%) |
| Sep 2022 | - | 91.86%(+0.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | 91.56%(+0.7%) |
| Mar 2022 | - | 90.92%(+1.0%) |
| Dec 2021 | 90.17%(-1.6%) | 90.05%(-0.8%) |
| Sep 2021 | - | 90.74%(+1.6%) |
| Jun 2021 | - | 89.27%(-1.5%) |
| Mar 2021 | - | 90.66%(-0.2%) |
| Dec 2020 | 91.59% | 90.80%(-1.8%) |
| Sep 2020 | - | 92.45%(-0.8%) |
| Jun 2020 | - | 93.15%(+1.1%) |
| Mar 2020 | - | 92.15% |
FAQ
- What is Intra-Cellular Therapies annual gross profit margin?
- What is the all time high annual gross margin for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies annual gross margin year-on-year change?
- What is Intra-Cellular Therapies quarterly gross profit margin?
- What is the all time high quarterly gross margin for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies quarterly gross margin year-on-year change?
What is Intra-Cellular Therapies annual gross profit margin?
The current annual gross margin of ITCI is 92.70%
What is the all time high annual gross margin for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high annual gross profit margin is 92.70%
What is Intra-Cellular Therapies annual gross margin year-on-year change?
Over the past year, ITCI annual gross profit margin has changed by +0.91% (+0.99%)
What is Intra-Cellular Therapies quarterly gross profit margin?
The current quarterly gross margin of ITCI is 91.26%
What is the all time high quarterly gross margin for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high quarterly gross profit margin is 93.50%
What is Intra-Cellular Therapies quarterly gross margin year-on-year change?
Over the past year, ITCI quarterly gross profit margin has changed by 0.00% (0.00%)